Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder
- First Posted Date
- 2021-07-01
- Last Posted Date
- 2021-07-01
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 440
- Registration Number
- NCT04948151
- Locations
- 🇺🇸
Coastal Connecticut Research, LLC, New London, Connecticut, United States
🇺🇸Intimmedicine Specialists, Washington, District of Columbia, United States
🇺🇸Southern Institute for Women's Sexual Health, Covington, Louisiana, United States
Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS)
- Conditions
- Interventions
- First Posted Date
- 2015-11-05
- Last Posted Date
- 2016-10-13
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 156
- Registration Number
- NCT02597634
- Locations
- 🇺🇸
Site #202, Springfield, Missouri, United States
🇺🇸Site #203, Hollywood, Florida, United States
🇺🇸Site #201, South Miami, Florida, United States
Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder
- First Posted Date
- 2015-10-07
- Last Posted Date
- 2017-10-03
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 31
- Registration Number
- NCT02570282
- Locations
- 🇺🇸
The Sexual Psychophysiology Laboratory, Austin, Texas, United States
Phase 2a Topical Sildenafil Proof-of-Concept Study in Men With Mild to Moderate ED
- Conditions
- Interventions
- First Posted Date
- 2015-03-18
- Last Posted Date
- 2017-10-12
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 33
- Registration Number
- NCT02390960
- Locations
- 🇺🇸
San Diego Sexual Medicine, San Diego, California, United States
🇺🇸Manhattan Medical Research, New York, New York, United States
🇺🇸Tulane Medical Center, New Orleans, Louisiana, United States
A Open-Label, Within-Subject Dose-Escalation Study to Evaluate the Clinical Safety and Pharmacokinetic Profile of a Topical Sildenafil Cream (5% w/w), in Healthy Postmenopausal Women
- First Posted Date
- 2015-02-18
- Last Posted Date
- 2015-06-22
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 21
- Registration Number
- NCT02364882
- Locations
- 🇺🇸
Clinical Pharmacology of Miami, Inc., Miami, Florida, United States
Dosing Interval Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness
- First Posted Date
- 2015-01-15
- Last Posted Date
- 2016-09-09
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 72
- Registration Number
- NCT02339129
- Locations
- 🇺🇸
Site #201, South Miami, Florida, United States
🇺🇸Site #202, Springfield, Missouri, United States
Single-Dose Relative Bioavailability Study of SST-6006, a Topical Sildenafil Cream Versus Oral Sildenafil in Healthy Male Adults
- Conditions
- Interventions
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2014-01-27
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 62
- Registration Number
- NCT01986673
- Locations
- 🇺🇸
SST Clinical Site, Miami, Florida, United States
Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2014-01-27
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 14
- Registration Number
- NCT01986660
- Locations
- 🇺🇸
SST Investigational Site, New York, New York, United States
Efficacy and Safety of SST 0225, a Topical Ibuprofen Cream, in the Treatment of Pain Associated With Acute Ankle Sprain
- Conditions
- Interventions
- First Posted Date
- 2013-06-11
- Last Posted Date
- 2021-05-21
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 305
- Registration Number
- NCT01874626
- Locations
- 🇺🇸
Ce3, Guilford, Connecticut, United States